Mechanisms of estradiol in fear circuitry: Implications for sex differences in psychopathology

Translational Psychiatry

Volumn 4, Issue , 2014, Pages

  Cover, K K ^a   Maeng, L Y ^a,b   Lebron Milad K ^a,b   Milad, M R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRADIOL RECEPTOR; G PROTEIN COUPLED RECEPTOR; SEX HORMONE; TESTOSTERONE; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTETROL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROGESTERONE;

ANXIETY DISORDER; CELL MEMBRANE; FEAR; GENOMICS; HUMAN; INCIDENCE; LIFESPAN; MENTAL DISEASE; MOOD DISORDER; NERVE CELL PLASTICITY; NONHUMAN; REVIEW; SEX DIFFERENCE; ANIMAL; ANXIETY DISORDERS; BRAIN; CONDITIONED REFLEX; FEMALE; MALE; MOUSE; NERVE CELL NETWORK; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RAT; REINFORCEMENT; SEXUAL DEVELOPMENT; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; BASOLATERAL AMYGDALA; BRAIN CORTEX; CENTRAL NUCLEUS (AMYGDALA); COGNITION; CYTOPLASM; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; HIPPOCAMPUS; HYPOTHALAMUS; INFRALIMBIC CORTEX; MEMORY CONSOLIDATION; MESENCEPHALON; MOLECULAR PATHOLOGY; NEUROIMAGING; PANIC; POSTTRAUMATIC STRESS DISORDER; PRELIMBIC CORTEX; VENTROMEDIAL PREFRONTAL CORTEX;

ANIMALS; ANXIETY DISORDERS; BRAIN; CONDITIONING, CLASSICAL; ESTRADIOL; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; HUMANS; MALE; MICE; NERVE NET; RATS; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 84907335790     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.67     Document Type: Review

References (151)

1. Milad MR, Quirk GJ. Fear extinction as a model for translational neuroscience: Ten years of progress. Annu Rev Psychol 2012; 63: 129-151.
2. Cahill L. A half-truth is a whole lie: On the necessity of investigating sex influences on the brain. Endocrinology 2012; 153: 2541-2543.
3. Kilpatrick DG, Resnick HS, Milanak ME, Miller MW, Keyes KM, Friedman MJ. National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. J Trauma Stress 2013; 26: 537-547.
4. Breslau N. Gender differences in trauma and posttraumatic stress disorder. J Gend Specif Med 2002; 5: 34-40. (Pubitemid 34467387)
5. Perrin M, Vandeleur CL, Castelao E, Rothen S, Glaus J, Vollenweider P et al. Determinants of the development of post-traumatic stress disorder, in the general population. Soc Psychiatry Psychiatr Epidemiol 2013; 49: 447-457.
6. Frans O, Rimmo PA, Aberg L, Fredrikson M. Trauma exposure and post-traumatic stress disorder in the general population. Acta Psychiatr Scand 2005; 111: 291-299. (Pubitemid 40445034)
7. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P. Trauma and posttraumatic stress disorder in the community: The 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry 1998; 55: 626-632. (Pubitemid 28340351)
8. Seedat S, Stein DJ, Carey PD. Post-traumatic stress disorder in women: Epidemiological and treatment issues. CNS Drugs 2005; 19: 411-427. (Pubitemid 41124015)
9. Hlbrook TL, Hoyt DB, Stein MB, Sieber WJ. Gender differences in long-term posttraumatic stress disorder outcomes after major trauma: Women are at higher risk of adverse outcomes than men. J Trauma 2002; 53: 882-888. (Pubitemid 35334782)
10. Labad J, Menchon JM, Alonso P, Segalas C, Jimenez S, Jaurrieta N et al. Gender differences in obsessive-compulsive symptom dimensions. Depress Anxiety 2008; 25: 832-838.
11. Labad J, Menchon JM, Alonso P, Segalas C, Jimenez S, Vallejo J. Female reproductive cycle and obsessive-compulsive disorder. J Clin Psychiatry 2005; 66: 428-435. (Pubitemid 40593570)
12. Bakish D. The patient with comorbid depression and anxiety: The unmet need. J Clin Psychiatry 1999; 60: 20-24. (Pubitemid 29210627)
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5, 5th edn. American Psychiatric Publishing: Washington, DC, USA, 2013.
14. Reed V, Wittchen HU. DSM-IV panic attacks and panic disorder in a community sample of adolescents and young adults: How specific are panic attacks? J Psychiatr Res 1998; 32: 335-345. (Pubitemid 28491238)
15. Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63: 415-424.
16. Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: A continuum of vulnerability? J Psychiatry Neurosci 2008; 33: 331-343. (Pubitemid 351977159)
17. Callegari C, Buttarelli M, Cromi A, Diurni M, Salvaggio F, Bolis PF. Female psychopathologic profile during menopausal transition: A preliminary study. Maturitas 2007; 56: 447-451. (Pubitemid 46401100)
18. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52: 1048-1060.
19. Eaton NR, Keyes KM, Krueger RF, Balsis S, Skodol AE, Markon KE et al. An invariant dimensional liability model of gender differences in mental disorder prevalence: Evidence from a national sample. J Abnorm Psychol 2012; 121: 282-288.
20. Somers JM, Goldner EM, Waraich P, Hsu L. Prevalence and incidence studies of anxiety disorders: A systematic review of the literature. Can J Psychiatry 2006; 51: 100-113.
21. Weili X Camilla F Hui-Xin W. Epidemiology of Alzheimer's Disease. In: Zerr, I (ed). Understanding Alzheimer's Disease. Intech: Hampshire, UK, 2013.
22. Diflorio A, Jones I. Is sex important? Gender differences in bipolar disorder. Int Rev Psychiatry 2010; 22: 437-452.
23. Abel KM, Drake R, Goldstein JM. Sex differences in schizophrenia. Int Rev Psychiatry 2010; 22: 417-428.
24. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA et al. Incidence of Parkinson's disease: Variation by age, gender, and race/ethnicity. Am J Epidemiol 2003; 157: 1015-1022. (Pubitemid 36628805)
25. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007; 64: 566-576. (Pubitemid 46718289)
26. Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics 2012; 9: 490-499.
27. Fireman B, Koran LM, Leventhal JL, Jacobson A. The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization. Am J Psychiatry 2001; 158: 1904-1910. (Pubitemid 33054786)
28. Quirk GJ, Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008; 33: 56-72. (Pubitemid 350191313)
29. Orsini CA, Maren S. Neural and cellular mechanisms of fear and extinction memory formation. Neurosci Biobehav Rev 2012; 36: 1773-1802.
30. Herry C, Ferraguti F, Singewald N, Letzkus JJ, Ehrlich I, Luthi A. Neuronal circuits of fear extinction. Eur J Neurosci 2010; 31: 599-612.
31. Pare D, Duvarci S. Amygdala microcircuits mediating fear expression and extinction. Curr Opin Neurobiol 2012; 22: 717-723.
32. Burgos-Robles A, Vidal-Gonzalez I, Quirk GJ. Sustained conditioned responses in prelimbic prefrontal neurons are correlated with fear expression and extinction failure. J Neurosci 2009; 29: 8474-8482.
33. Amir A, Amano T, Pare D. Physiological identification and infralimbic responsiveness of rat intercalated amygdala neurons. J Neurophysiol 2011; 105: 3054-3066.
34. Sotres-Bayon F, Sierra-Mercado D, Pardilla-Delgado E, Quirk GJ. Gating of fear in prelimbic cortex by hippocampal and amygdala inputs. Neuron 2012; 76: 804-812.
35. Linnman C, Zeidan MA, Furtak SC, Pitman RK, Quirk GJ, Milad MR. Resting amygdala and medial prefrontal metabolism predicts functional activation of the fear extinction circuit. Am J Psychiatry 2012; 169: 415-423.
36. Phelps EA, Delgado MR, Nearing KI, LeDoux JE. Extinction learning in humans: Role of the amygdala and vmPFC. Neuron 2004; 43: 897-905. (Pubitemid 39215019)
37. Kalisch R, Korenfeld E, Stephan KE, Weiskopf N, Seymour B, Dolan RJ. Contextdependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. J Neurosci 2006; 26: 9503-9511. (Pubitemid 44396863)
38. Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry 2007; 62: 446-454. (Pubitemid 47284021)
39. Milad MR, Pitman RK, Ellis CB, Gold AL, Shin LM, Lasko NB et al. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry 2009; 66: 1075-1082.
40. Lanius RA, Williamson PC, Boksman K, Densmore M, Gupta M, Neufeld RW et al. Brain activation during script-driven imagery induced dissociative responses in PTSD: A functional magnetic resonance imaging investigation. Biol Psychiatry 2002; 52: 305-311. (Pubitemid 35245969)
41. Zubieta JK, Chinitz JA, Lombardi U, Fig LM, Cameron OG, Liberzon I. Medial frontal cortex involvement in PTSD symptoms: A SPECT study. J Psychiatr Res 1999; 33: 259-264. (Pubitemid 29178669)
42. Liberzon I, Taylor SF, Amdur R, Jung TD, Chamberlain KR, Minoshima S et al. Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry 1999; 45: 817-826. (Pubitemid 29188020)
43. Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines. Pharmacol Rev 2010; 62: 155-198.
44. Celotti F, Melcangi RC, Negri-Cesi P, Poletti A. Testosterone metabolism in brain cells and membranes. J Steroid Biochem Mol Biol 1991; 40: 673-678.
45. Jones ME, Boon WC, Proietto J, Simpson ER. Of mice and men: The evolving phenotype of aromatase deficiency. Trends Endocrinol Metab 2006; 17: 55-64.
46. Roselli CF. Brain aromatase: Roles in reproduction and neuroprotection. J Steroid Biochem Mol Biol 2007; 106: 143-150. (Pubitemid 47362653)
47. Hess RA. Estrogen in the adult male reproductive tract: A review. Reprod Biol Endocrinol 2003; 1: 52.
48. Ogawa S, Eng V, Taylor J, Lubahn DB, Korach KS, Pfaff DW. Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology 1998; 139: 5070-5081. (Pubitemid 28533455)
49. Jacome LF, Gautreaux C, Inagaki T, Mohan G, Alves S, Lubbers LS et al. Estradiol and ERbeta agonists enhance recognition memory, and DPN, an ERbeta agonist, alters brain monoamines. Neurobiol Learn Mem 2010; 94: 488-498.
50. Oyola MG, Portillo W, Reyna A, Foradori CD, Kudwa A, Hinds L et al. Anxiolytic effects and neuroanatomical targets of estrogen receptor-beta (ERbeta) activation by a selective ERbeta agonist in female mice. Endocrinology 2012; 153: 837-846.
51. Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: Anatomical evidence of distinct roles of each subtype. J Neurobiol 1998; 36: 357-378. (Pubitemid 28397147)
52. Zhang JQ, Cai WQ, Su BY, Zhou de S. Immunocytochemical localization of estrogen receptor beta in the rat brain. Shi Yan Sheng Wu Xue Bao 2002; 35: 15-20.
53. Weiser MJ, Foradori CD, Handa RJ. Estrogen receptor beta in the brain: From form to function. Brain Res Rev 2008; 57: 309-320. (Pubitemid 351381766)
54. Kritzer MF. Regional, laminar, and cellular distribution of immunoreactivity for ER alpha and ER beta in the cerebral cortex of hormonally intact, adult male and female rats. Cereb Cortex 2002; 12: 116-128. (Pubitemid 34052968)
55. Osterlund M, Kuiper GG, Gustafsson JA, Hurd YL. Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res Mol Brain Res 1998; 54: 175-180. (Pubitemid 28119175)
56. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 1997; 388: 507-525. (Pubitemid 27481288)
57. Mendoza-Garces L, Mendoza-Rodriguez CA, Jimenez-Trejo F, Picazo O, Rodriguez MC, Cerbon M. Differential expression of estrogen receptors in two hippocampal regions during the estrous cycle of the rat. Anat Rec (Hoboken ) 2011; 294: 1913-1919.
58. Montague D, Weickert CS, Tomaskovic-Crook E, Rothmond DA, Kleinman JE, Rubinow DR. Oestrogen receptor alpha localisation in the prefrontal cortex of three mammalian species. J Neuroendocrinol 2008; 20: 893-903. (Pubitemid 351859107)
59. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 3rd edn. Academic Press: Orlando, FL, USA, 1997.
60. Shughrue PJ, Bushnell CD, Dorsa DM. Estrogen receptor messenger ribonucleic acid in female rat brain during the estrous cycle: A comparison with ovariectomized females and intact males. Endocrinology 1992; 131: 381-388.
61. Navarro A, Del VE, Ordonez C, Martinez E, Perez C, Alonso A et al. Aging and substitutive hormonal therapy influence in regional and subcellular distribution of ERalpha in female rat brain. Age (Dordr ) 2013; 35: 821-837.
62. Lebron-Milad K, Milad MR. Sex differences, gonadal hormones and the fear extinction network: Implications for anxiety disorders. Biol Mood Anxiety Disord 2012; 2: 3.
63. Rivas-Arancibia S, Vazquez-Pereyra F. Hormonal modulation of extinction responses induced by sexual steroid hormones in rats. Life Sci 1994; 54: L363-L367. (Pubitemid 24180089)
64. Yuan DL, Chambers KC. Estradiol accelerates extinction of a conditioned taste aversion in female and male rats. Horm Behav 1999; 36: 1-16. (Pubitemid 29382842)
65. Milad MR, Igoe SA, Lebron-Milad K, Novales JE. Estrous cycle phase and gonadal hormones influence conditioned fear extinction. Neuroscience 2009; 164: 887-895.
66. Zeidan MA, Igoe SA, Linnman C, Vitalo A, Levine JB, Klibanski A et al. Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biol Psychiatry 2011; 70: 920-927.
67. Cahill L, Gorski L, Le K. Enhanced human memory consolidation with postlearning stress: Interaction with the degree of arousal at encoding. Learn Mem 2003; 10: 270-274. (Pubitemid 37013066)
68. Goldstein JM, Jerram M, Poldrack R, Ahern T, Kennedy DN, Seidman LJ et al. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci 2005; 25: 9309-9316. (Pubitemid 41500840)
69. Amin Z, Epperson CN, Constable RT, Canli T. Effects of estrogen variation on neural correlates of emotional response inhibition. Neuroimage 2006; 32: 457-464.
70. Glover EM, Mercer KB, Norrholm SD, Davis M, Duncan E, Bradley B et al. Inhibition of fear is differentially associated with cycling estrogen levels in women. J Psychiatry Neurosci 2013; 38: 341-348.
71. Shvil E, Sullivan GM, Schafer S, Markowitz JC, Campeas M, Wager TD et al. Sex differences in extinction recall in posttraumatic stress disorder: A pilot fMRI study. Neurobiol Learn Mem 2014; 113: 101-108.
72. Inslicht SS, Metzler TJ, Garcia NM, Pineles SL, Milad MR, Orr SP et al. Sex differences in fear conditioning in posttraumatic stress disorder. J Psychiatr Res 2013; 47: 64-71.
73. Glover EM, Jovanovic T, Mercer KB, Kerley K, Bradley B, Ressler KJ et al. Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder. Biol Psychiatry 2012; 72: 19-24.
74. Herry C, Trifilieff P, Micheau J, Luthi A, Mons N. Extinction of auditory fear conditioning requires MAPK/ERK activation in the basolateral amygdala. Eur J Neurosci 2006; 24: 261-269. (Pubitemid 44050685)
75. Hugues S, Chessel A, Lena I, Marsault R, Garcia R. Prefrontal infusion of PD098059 immediately after fear extinction training blocks extinction- associated prefrontal synaptic plasticity and decreases prefrontal ERK2 phosphorylation. Synapse 2006; 60: 280-287. (Pubitemid 44134348)
76. Lu KT, Walker DL, Davis M. Mitogen-activated protein kinase cascade in the basolateral nucleus of amygdala is involved in extinction of fear-potentiated startle. J Neurosci 2001; 21: RC162.
77. Kim J, Park S, Lee S, Choi S. Amygdala depotentiation ex vivo requires mitogenactivated protein kinases and protein synthesis. Neuroreport 2009; 20: 517-520.
78. Santini E, Ge H, Ren K, Pena de OS, Quirk GJ. Consolidation of fear extinction requires protein synthesis in the medial prefrontal cortex. J Neurosci 2004; 24: 5704-5710. (Pubitemid 38857224)
79. Matsuda S, Matsuzawa D, Nakazawa K, Sutoh C, Ohtsuka H, Ishii D et al. d-serine enhances extinction of auditory cued fear conditioning via ERK1/2 phosphorylation in mice. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 895-902.
80. Chen X, Garelick MG, Wang H, Lil V, Athos J, Storm DR. PI3 kinase signaling is required for retrieval and extinction of contextual memory. Nat Neurosci 2005; 8: 925-931.
81. Lin CH, Lee CC, Gean PW. Involvement of a calcineurin cascade in amygdala depotentiation and quenching of fear memory. Mol Pharmacol 2003; 63: 44-52.
82. Kritman M, Maroun M. Inhibition of the PI3 kinase cascade in corticolimbic circuit: Temporal and differential effects on contextual fear and extinction. Int J Neuropsychopharmacol 2013; 16: 825-833.
83. Carbone DL, Handa RJ. Sex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor. Neuroscience 2013; 239: 295-303.
84. Peters J, Dieppa-Perea LM, Melendez LM, Quirk GJ. Induction of fear extinction with hippocampal-infralimbic BDNF. Science 2010; 328: 1288-1290.
85. Do-Monte FH, Rodriguez-Romaguera J, Rosas-Vidal LE, Quirk GJ. Deep brain stimulation of the ventral striatum increases BDNF in the fear extinction circuit. Front Behav Neurosci 2013; 7: 102.
86. Andero R, Ressler KJ. Fear extinction and BDNF: Translating animal models of PTSD to the clinic. Genes Brain Behav 2012; 11: 503-512.
87. Roepke TA, Ronnekleiv OK, Kelly MJ. Physiological consequences of membraneinitiated estrogen signaling in the brain. Front Biosci (Landmark Ed) 2011; 16: 1560-1573.
88. Mermelstein PG. Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors. J Neuroendocrinol 2009; 21: 257-262.
89. Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 2010; 204: 105-114.
90. Spencer-Segal JL, Tsuda MC, Mattei L, Waters EM, Romeo RD, Milner TA et al. Estradiol acts via estrogen receptors alpha and beta on pathways important for synaptic plasticity in the mouse hippocampal formation. Neuroscience 2012; 202: 131-146.
91. Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 2001; 276: 13615-13621.
92. Kushner PJ, Agard D, Feng WJ, Lopez G, Schiau A, Uht R et al. Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp 2000; 230: 20-26.
93. Roepke TA, Ronnekleiv OK, Kelly MJ. Physiological consequences of membraneinitiated estrogen signaling in the brain. Front Biosci (Landmark Ed) 2011; 16: 1560-1573.
94. Boulware MI, Weick JP, Becklund BR, Kuo SP, Groth RD, Mermelstein PG. Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J Neurosci 2005; 25: 5066-5078. (Pubitemid 40712851)
95. Huang GZ, Woolley CS. Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism. Neuron 2012; 74: 801-808.
96. Hojo Y, Higo S, Kawato S, Hatanaka Y, Ooishi Y, Murakami G et al. Hippocampal synthesis of sex steroids and corticosteroids: Essential for modulation of synaptic plasticity. Front Endocrinol (Lausanne) 2011; 2: 43.
97. Soltysik K, Czekaj P. Membrane estrogen receptors-is it an alternative way of estrogen action? J Physiol Pharmacol 2013; 64: 129-142.
98. Brailoiu E, Dun SL, Brailoiu GC, Mizuo K, Sklar LA, Oprea TI et al. Distribution and characterization of estrogen receptor G protein-coupled receptor in the rat central nervous system. J Endocrinol 2007; 193: 311-321.
99. Gingerich S, Kim GL, Chalmers JA, Koletar MM, Wang X, Wang Y et al. Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17beta-estradiol in novel murine hippocampal cell models. Neuroscience 2010; 170: 54-66.
100. Kastenberger I, Lutsch C, Schwarzer C. Activation of the G-protein-coupled receptor GPR30 induces anxiogenic effects in mice, similar to oestradiol. Psychopharmacology (Berl) 2012; 221: 527-535.
101. Hart D, Nilges M, Pollard K, Lynn T, Patsos O, Shiel C et al. Activation of the G-protein coupled receptor 30 (PR30) has different effects on anxiety in male and female mice. Steroids 2014; 81: 49-56.
102. Tanapat P, Hastings NB, Reeves AJ, Gould E. Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J Neurosci 1999; 19: 5792-5801. (Pubitemid 29327916)
103. Barker JM, Galea LA. Repeated estradiol administration alters different aspects of neurogenesis and cell death in the hippocampus of female, but not male, rats. Neuroscience 2008; 152: 888-902.
104. Shors TJ, Townsend DA, Zhao M, Kozorovitskiy Y, Gould E. Neurogenesis may relate to some but not all types of hippocampal-dependent learning. Hippocampus 2002; 12: 578-584. (Pubitemid 35363952)
105. Epp JR, Chow C, Galea LA. Hippocampus-dependent learning influences hippocampal neurogenesis. Front Neurosci 2013; 7: 57.
106. Smith CC, McMahon LL. Estradiol-induced increase in the magnitude of longterm potentiation is prevented by blocking NR2B-containing receptors. J Neurosci 2006; 26: 8517-8522. (Pubitemid 44316180)
107. Wallace M, Luine V, Arellanos A, Frankfurt M. Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Res 2006; 1126: 176-182. (Pubitemid 44880922)
108. Woolley CS, Gould E, Frankfurt M, McEwen BS. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 1990; 10: 4035-4039.
109. Kato A, Hojo Y, Higo S, Komatsuzaki Y, Murakami G, Yoshino H et al. Female hippocampal estrogens have a significant correlation with cyclic fluctuation of hippocampal spines. Front Neural Circuits 2013; 7: 149.
110. Srivastava DP, Penzes P. Rapid estradiol modulation of neuronal connectivity and its implications for disease. Front Endocrinol (Lausanne) 2011; 2: 77.
111. Luine V, Frankfurt M. Interactions between estradiol, BDNF and dendritic spines in promoting memory. Neuroscience 2013; 239: 34-45.
112. Singh M, Meyer EM, Simpkins JW. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague- Dawley rats. Endocrinology 1995; 136: 2320-2324.
113. Pan Y, Anthony M, Clarkson TB. Evidence for up-regulation of brain-derived neurotrophic factor mRNA by soy phytoestrogens in the frontal cortex of retired breeder female rats. Neurosci Lett 1999; 261: 17-20. (Pubitemid 29100065)
114. Aksamitiene E, Kiyatkin A, Kholodenko BN. Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: A fine balance. Biochem Soc Trans 2012; 40: 139-146.
115. Bean LA, Ianov L, Foster TC. Estrogen Receptors, the Hippocampus, and Memory. Neuroscientist 2014.
116. Rosas-Vidal LE, Do-Monte FH, Sotres-Bayon F, Quirk GJ. Hippocampal-prefrontal BDNF and memory for fear extinction. Neuropsychopharmacology 2014; 39: 2161-2169.
117. Milad MR, Zeidan MA, Contero A, Pitman RK, Klibanski A, Rauch SL et al. The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience 2010; 168: 652-658.
118. Toufexis DJ, Davis C, Hammond A, Davis M. Progesterone attenuates corticotropinreleasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J Neurosci 2004; 24: 10280-10287. (Pubitemid 39492055)
119. Pibiri F, Nelson M, Guidotti A, Costa E, Pinna G. Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder. Proc Natl Acad Sci U S A 2008; 105: 5567-5572. (Pubitemid 351753903)
120. Sripada RK, Marx CE, King AP, Rampton JC, Ho SS, Liberzon I. Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits. Biol Psychiatry 2013; 73: 1045-1053.
121. Sripada RK, Welsh RC, Marx CE, Liberzon I. The neurosteroids allopregnanolone and dehydroepiandrosterone modulate resting-state amygdala connectivity. Hum Brain Mapp 2013; 35: 3249-3261.
122. Frye CA, Koonce CJ, Edinger KL, Osborne DM, Walf AA. Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice. Horm Behav 2008; 54: 726-734.
123. Hodosy J, Zelmanova D, Majzunova M, Filova B, Malinova M, Ostatnikova D et al. The anxiolytic effect of testosterone in the rat is mediated via the androgen receptor. Pharmacol Biochem Behav 2012; 102: 191-195.
124. McDermott CM, Liu D, Schrader LA. Role of gonadal hormones in anxiety and fear memory formation and inhibition in male mice. Physiol Behav 2012; 105: 1168-1174.
125. Graham BM, Milad MR. Inhibition of estradiol synthesis impairs fear extinction in male rats. Learn Mem 2014; 21: 347-350.
126. Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V et al. Testosterone replacement therapy improves mood in hypogonadal men-a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3578-3583. (Pubitemid 26339918)
127. Pace-Schott EF, Spencer RM, Vijayakumar S, Ahmed NA, Verga PW, Orr SP et al. Extinction of conditioned fear is better learned and recalled in the morning than in the evening. J Psychiatr Res 2013; 47: 1776-1784.
128. Patton GC, Hibbert ME, Carlin J, Shao Q, Rosier M, Caust J et al. Menarche and the onset of depression and anxiety in Victoria, Australia. J Epidemiol Community Health 1996; 50: 661-666. (Pubitemid 27036147)
129. Reed SC, Levin FR, Evans SM. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder). Horm Behav 2008; 54: 185-193.
130. Epperson CN, Sammel MD, Freeman EW. Menopause effects on verbal memory: Findings from a longitudinal community cohort. J Clin Endocrinol Metab 2013; 98: 3829-3838.
131. Freeman EW. Associations of depression with the transition to menopause. Menopause 2010; 17: 823-827.
132. Kammerer M, Adams D, Castelberg Bv, Glover V. Pregnant women become insensitive to cold stress. BMC Pregnancy Childbirth 2002; 2: 8.
133. Vesga-Lopez O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008; 65: 805-815. (Pubitemid 351957706)
134. Moses-Kolko EL, Roth EK. Antepartum and postpartum depression: Healthy mom, healthy baby. J Am Med Womens Assoc 2004; 59: 181-191.
135. Ahokas A, Kaukoranta J, Wahlbeck K, Aito M. Estrogen deficiency in severe postpartum depression: Successful treatment with sublingual physiologic 17beta-estradiol: A preliminary study. J Clin Psychiatry 2001; 62: 332-336. (Pubitemid 32545553)
136. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996; 347: 930-933. (Pubitemid 26102548)
137. Sichel DA, Cohen LS, Robertson LM, Ruttenberg A, Rosenbaum JF. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995; 38: 814-818.
138. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58: 529-534. (Pubitemid 32523731)
139. Schneider LS, Small GW, Clary CM. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am J Geriatr Psychiatry 2001; 9: 393-399. (Pubitemid 33015126)
140. Best NR, Rees MP, Barlow DH, Cowen PJ. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 1992; 17: 87-93.
141. Petersen N, Kilpatrick LA, Goharzad A, Cahill L. Oral contraceptive pill use and menstrual cycle phase are associated with altered resting state functional connectivity. Neuroimage 2013; 90C: 24-32.
142. Graham BM, Milad MR. Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women. Biol Psychiatry 2013; 73: 371-378.
143. Ferree NK, Wheeler M, Cahill L. The influence of emergency contraception on post-traumatic stress symptoms following sexual assault. J Forensic Nurs 2012; 8: 122-130.
144. Mordecai KL, Rubin LH, Maki PM. Effects of menstrual cycle phase and oral contraceptive use on verbal memory. Horm Behav 2008; 54: 286-293.
145. Gogos A. Natural and synthetic sex hormones: Effects on higher-order cognitive function and prepulse inhibition. Biol Psychol 2013; 93: 17-23.
146. Nielsen SE, Ahmed I, Cahill L. Sex and menstrual cycle phase at encoding influence emotional memory for gist and detail. Neurobiol Learn Mem 2013; 106: 56-65.
147. Nielsen SE, Ertman N, Lakhani YS, Cahill L. Hormonal contraception usage is associated with altered memory for an emotional story. Neurobiol Learn Mem 2011; 96: 378-384.
148. Pletzer B, Kronbichler M, Nuerk HC, Kerschbaum H. Hormonal contraceptives masculinize brain activation patterns in the absence of behavioral changes in two numerical tasks. Brain Res 2014; 1543: 128-142.
149. Griksiene R, Ruksenas O. Effects of hormonal contraceptives on mental rotation and verbal fluency. Psychoneuroendocrinology 2011; 36: 1239-1248.
150. Svendal G, Berk M, Pasco JA, Jacka FN, Lund A, Williams LJ. The use of hormonal contraceptive agents and mood disorders in women. J Affect Disord 2012; 140: 92-96.
151. Frye CA, Edinger KL. Testosterone's metabolism in the hippocampus may mediate its anti-anxiety effects in male rats. Pharmacol Biochem Behav 2004; 78: 473-481. (Pubitemid 38901015)